"Stupid" French finance bill set to add 30-40% to biotech wage costs, says France Biotech
This article was originally published in Scrip
Executive Summary
Article 78 of the Finance Bill currently going through the French parliament system will cost research-based French biotechnology companies 30-40% more in increased salaries and will emasculate the advantageous tax status currently enjoyed by Jeunes Enterprises Innovantes (JEI: Young Innovative Companies), according to the French biotechnology industry association, France Biotechnology.